167 related articles for article (PubMed ID: 18034699)
21. Transforming growth factor-beta regulation of estradiol-induced prolactinomas.
Hentges S; Sarkar DK
Front Neuroendocrinol; 2001 Oct; 22(4):340-63. PubMed ID: 11587556
[TBL] [Abstract][Full Text] [Related]
22. Pituitary prolactin-secreting tumor formation: recent developments.
Xu RK; Wu XM; Di AK; Xu JN; Pang CS; Pang SF
Biol Signals Recept; 2000; 9(1):1-20. PubMed ID: 10686432
[TBL] [Abstract][Full Text] [Related]
23. Sex differences in the pituitary transforming growth factor-β1 system: studies in a model of resistant prolactinomas.
Recouvreux MV; Lapyckyj L; Camilletti MA; Guida MC; Ornstein A; Rifkin DB; Becu-Villalobos D; Díaz-Torga G
Endocrinology; 2013 Nov; 154(11):4192-205. PubMed ID: 24008346
[TBL] [Abstract][Full Text] [Related]
24. Antiproliferative action of calcitonin on lactotrophs of the rat anterior pituitary gland: evidence for the involvement of transforming growth factor beta 1 in calcitonin action.
Wang YQ; Yuan R; Sun YP; Lee TJ; Shah GV
Endocrinology; 2003 May; 144(5):2164-71. PubMed ID: 12697724
[TBL] [Abstract][Full Text] [Related]
25. The pituitary TGFβ1 system as a novel target for the treatment of resistant prolactinomas.
Recouvreux MV; Camilletti MA; Rifkin DB; Díaz-Torga G
J Endocrinol; 2016 Mar; 228(3):R73-83. PubMed ID: 26698564
[TBL] [Abstract][Full Text] [Related]
26. Dopamine, dopamine D2 receptor short isoform, transforming growth factor (TGF)-beta1, and TGF-beta type II receptor interact to inhibit the growth of pituitary lactotropes.
Sarkar DK; Chaturvedi K; Oomizu S; Boyadjieva NI; Chen CP
Endocrinology; 2005 Oct; 146(10):4179-88. PubMed ID: 15961557
[TBL] [Abstract][Full Text] [Related]
27. Colocalization of prolactin and proliferating cell nuclear antigen in the anterior pituitary during estrogen-induced pituitary tumors.
Banerjee SK; De A; Sarkar DK
Cancer Lett; 1994 Dec; 87(2):139-44. PubMed ID: 7812932
[TBL] [Abstract][Full Text] [Related]
28. Temporal effects of estradiol and diethylstilbestrol on pituitary and plasma prolactin levels in ovariectomized Fischer 344 and Holtzman rats: a comparison of radioimmunoassay and Nb2 lymphoma cell bioassay.
Moy J; Lawson D
Proc Soc Exp Biol Med; 1992 Sep; 200(4):507-13. PubMed ID: 1508941
[TBL] [Abstract][Full Text] [Related]
29. [Effects of growth factors and estrogen on the proliferation and prolactin gene expression in anterior pituitary cells of rats].
Wu X; Zhang R; Di A; Shan H; Xu R
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1999 Oct; 21(5):331-7. PubMed ID: 12567429
[TBL] [Abstract][Full Text] [Related]
30. Possible involvement of transforming growth factor-beta in the inhibition of rat pituitary tumor growth by estradiol.
Albaladejo V; Feï ZL; Nicolas B; Joly-Pharaboz MO; Avallet O; Vigier M; André J
J Steroid Biochem Mol Biol; 1992 Feb; 41(2):125-34. PubMed ID: 1543679
[TBL] [Abstract][Full Text] [Related]
31. Estrogen actions on lactotroph proliferation are independent of a paracrine interaction with other pituitary cell types: a study using lactotroph-enriched cells.
Ishida M; Takahashi W; Itoh S; Shimodaira S; Maeda S; Arita J
Endocrinology; 2007 Jul; 148(7):3131-9. PubMed ID: 17412817
[TBL] [Abstract][Full Text] [Related]
32. Transforming growth factor-beta3 increases gap-junctional communication among folliculostellate cells to release basic fibroblast growth factor.
Kabir N; Chaturvedi K; Liu LS; Sarkar DK
Endocrinology; 2005 Sep; 146(9):4054-60. PubMed ID: 15961560
[TBL] [Abstract][Full Text] [Related]
33. Genesis of prolactinomas: studies using estrogen-treated animals.
Sarkar DK
Front Horm Res; 2006; 35():32-49. PubMed ID: 16809921
[TBL] [Abstract][Full Text] [Related]
34. Estrogen inhibits D2S receptor-regulated Gi3 and Gs protein interactions to stimulate prolactin production and cell proliferation in lactotropic cells.
Sengupta A; Sarkar DK
J Endocrinol; 2012 Jul; 214(1):67-78. PubMed ID: 22573829
[TBL] [Abstract][Full Text] [Related]
35. Paeoniflorin ameliorates antipsychotic-induced hyperprolactinemia in rats by attenuating impairment of the dopamine D2 receptor and TGF-β1 signaling pathways in the hypothalamus and pituitary.
Huang X; Ren L; Hou L; Fan H; Wang C; Wang C; Li Y
J Ethnopharmacol; 2020 Jul; 257():112862. PubMed ID: 32294507
[TBL] [Abstract][Full Text] [Related]
36. Early involvement of estrogen-induced pituitary tumor transforming gene and fibroblast growth factor expression in prolactinoma pathogenesis.
Heaney AP; Horwitz GA; Wang Z; Singson R; Melmed S
Nat Med; 1999 Nov; 5(11):1317-21. PubMed ID: 10546001
[TBL] [Abstract][Full Text] [Related]
37. Role of growth factors and estrogen as modulators of growth, differentiation, and expression of gonadotropin subunit genes in primary cultured sheep pituitary cells.
Chaidarun SS; Eggo MC; Stewart PM; Barber PC; Sheppard MC
Endocrinology; 1994 Feb; 134(2):935-44. PubMed ID: 8299588
[TBL] [Abstract][Full Text] [Related]
38. Cell proliferation and death in the irradiated pituitary gland and its modification by growth stimulants.
Guo YP; Hendry JH; Morris ID; Davis JR; Beardwell CG
Int J Radiat Oncol Biol Phys; 1997 Apr; 38(1):175-81. PubMed ID: 9212021
[TBL] [Abstract][Full Text] [Related]
39. Transforming growth factor-alpha and -beta are potent and effective inhibitors of GH4 pituitary tumor cell proliferation.
Ramsdell JS
Endocrinology; 1991 Apr; 128(4):1981-90. PubMed ID: 2004614
[TBL] [Abstract][Full Text] [Related]
40. Changes in thrombospondin-1 levels in the endothelial cells of the anterior pituitary during estrogen-induced prolactin-secreting pituitary tumors.
Sarkar AJ; Chaturvedi K; Chen CP; Sarkar DK
J Endocrinol; 2007 Feb; 192(2):395-403. PubMed ID: 17283240
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
